Gem'S First Annual Report Today Unveiled &Nbsp; Xinghe'S Biological Performance Doubled.

Yesterday evening, two companies listed on the gem annual report, Xinghe Biology (300143, stock bar) (300143.SZ) "topped the list" first announced in 2010.

Belonging to the chemical industry, Shuanglong shares (300108, stock bar) (300108.SZ) belonging to the shareholders of listed companies accounted for 24382113.83 yuan, a 3.71% increase compared with that of Xinghe.

Star River Biological sales increase

According to the annual report of Xinghe biology, in 2010, the company achieved operating income of 167931537.22 yuan, an increase of 75.35% over the same period last year, and the total profit was 42562265.17 yuan, an increase of 108.75% over the same period last year. The net profit was 42203515.03 yuan, up 107.39% over the same period last year.

For the big increase in performance, the company said that the main reason is that the company's capacity has been greatly improved and its product structure has been continuously optimized.

The company is located in Dongguan, Guangdong, and has been involved in the mushroom industry since 2000.

In December 2010, the initial public offering of A shares was 567 million 887 thousand and 500 yuan.

At present, the main products include three kinds of fresh mushrooms, Flammulina velutipes, mushroom and white mushroom.

Among them, Baiyu mushroom business income increased by 209.64% over last year.

In terms of three charges, the increase in sales costs was the largest, up 90.7% from the same period last year, reaching 12 million 300 thousand yuan.

Sales expenses are mainly from

The management cost reached 21 million 170 thousand yuan, an increase of 82.72% over the same period last year.

The company said that with the expansion of business scale, the increase of branches and the increase of management staff, the management staff's wages and welfare expenses increased rapidly.

Continuation of high delivery market

According to the annual report, the plan for the allocation of profits and capital surplus of Xinghe is as follows: 2010 does not allocate cash dividends, and the undistributed profits are pferred to the next year.

At the same time, the total share capital will be 67 million shares.

Shuanglong intends to distribute the cash dividend of 1.20 yuan (including tax) for every 10 shares of all shareholders on the basis of the total share capital of 52 million shares in December 31, 2010, and increase the capital stock by capital stock, increasing 3 shares per 10 shares, and the annual distribution of the remaining undistributed profits after the pfer.

Perhaps it is poor performance, compared with the first annual report released by the gem last year, the distribution plan of Xinghe and Shuanglong shares is not enough.

In the 2009 annual report, there is a "flush of China's first stock information", the annual revenue close to 200 million yuan mark, flush for this reason, 10 pferred to 10 schools 3 high allocation plan.

For the annual report of Shuanglong shares, insiders said bluntly: "the performance is not good enough.